Prolacta Bioscience Celebrates Prematurity Awareness Month by Recognizing Breast Milk Donors for Their Contributions to Premature Infants in the NICU
Type: Press Releases
Topic(s): Donors Helping Hands Tiny Treasures
Prolacta Bioscience Develops World’s First Test to Directly Detect Bacteria and Viruses, Including SARS-CoV-2, in Donor Breast Milk
Type: Press Releases
Topic(s): Company
Donor Jessica overcomes infertility and gets help paying off debts
Type: Donor Stories
Topic(s): Tiny Treasures
Mindy Fuzesy presents at Association of Women's Health, Obstetric and Neonatal Nurses 2021 virtual convention
Type: Press Releases
Topic(s): Conferences and Events Pasteurization
Prolacta Bioscience continues Advancing the Science of Human Milk, proud to partner with NICU teams in saving lives of premature infants
Type: Press Releases
Topic(s): Company Healthcare Professionals
The importance of data in an exclusive human milk diet: Key concepts and points of consideration
Type: Prolacta in the News
Topic(s): Pasteurization
Association of Women’s Health, Obstetric, & Neonatal Nurses (AWHONN) encourages an exclusive human milk diet (EHMD) for vulnerable preterm infants in the neonatal intensive care unit (NICU)
Type: Press Releases
Topic(s): Advocacy Bronchopulmonary Dysplasia (BPD) Feeding Intolerance Late-Onset Sepsis Mortality Necrotizing Entercolitis (NEC) Retinopathy of Prematurity (ROP)
JFL becomes first US Virgin Islands hospital to adopt Prolacta protocol for extremely premature NICU babies
Type: Prolacta in the News
Topic(s): Growth Neurodevelopmental Outcomes
Prolacta's role in advancing neonatal nutrition
Type:
Topic(s): Company